Figures & data
![](/cms/asset/c07dc9e5-f696-453e-8d46-12d2d67d3784/tbbb_a_1562880_uf0001_oc.jpg)
Figure 1. Schematic diagram of the reactions from ARA to PGF2α in the COX enzyme system.
PGG2, prostaglandin G2; PGH2, prostaglandin H2; PGF synthase, prostaglandin F synthase; PGF2α, prostaglandin F2α.
![Figure 1. Schematic diagram of the reactions from ARA to PGF2α in the COX enzyme system.PGG2, prostaglandin G2; PGH2, prostaglandin H2; PGF synthase, prostaglandin F synthase; PGF2α, prostaglandin F2α.](/cms/asset/8cb9c2aa-23dc-4ea1-b8ec-06f060744560/tbbb_a_1562880_f0001_b.gif)
Figure 2. Schematic diagram of the plasmid pBIG35ZhGvCOXm with the GvCOX gene downstream of the histone promoter.
GvCOXm, the codon-optimized GvCOX gene for M. alpina; hispro550 p, M. alpina histone protein promoter; SdhB t, M. alpina SdhB gene transcription terminator; ura5, the orotate phosphoribosyl transferase gene of M. alpina 1S-4; NPTIII, neomysin phosphotransferase III gene; TrfA, TrfA locus, which produces two proteins that promote the replication of the plasmid; ColE1 ori, ColE1 origin of replication; oriV, pRK2 origin of replication; RB and LB, the right and left border, respectively, from Ti-plasmid of A. tumefaciens.
![Figure 2. Schematic diagram of the plasmid pBIG35ZhGvCOXm with the GvCOX gene downstream of the histone promoter.GvCOXm, the codon-optimized GvCOX gene for M. alpina; hispro550 p, M. alpina histone protein promoter; SdhB t, M. alpina SdhB gene transcription terminator; ura5, the orotate phosphoribosyl transferase gene of M. alpina 1S-4; NPTIII, neomysin phosphotransferase III gene; TrfA, TrfA locus, which produces two proteins that promote the replication of the plasmid; ColE1 ori, ColE1 origin of replication; oriV, pRK2 origin of replication; RB and LB, the right and left border, respectively, from Ti-plasmid of A. tumefaciens.](/cms/asset/00f7371c-a29c-4e9b-9e12-8498c336aa44/tbbb_a_1562880_f0002_b.gif)
Figure 3. Evaluation of in vitro COX activity in the transformants.
Resting cells were used to convert 30.45 mg/L of ARA to PGF2α as described in Materials and Methods.
![Figure 3. Evaluation of in vitro COX activity in the transformants.Resting cells were used to convert 30.45 mg/L of ARA to PGF2α as described in Materials and Methods.](/cms/asset/512422d3-7d05-44e2-8c76-261ddf744e7d/tbbb_a_1562880_f0003_b.gif)
Figure 4. Evaluation of fermentative production of PGF2α that was released into the media during the 12-day cultivation of the transformants.
![Figure 4. Evaluation of fermentative production of PGF2α that was released into the media during the 12-day cultivation of the transformants.](/cms/asset/ccd920c6-a11e-4ea3-8b15-a0a6ac079ee7/tbbb_a_1562880_f0004_b.gif)
Figure 5. Fermentative intracellular production of prostaglandins F1α, F2α, and F3α in the parental (M. alpina 1S-4) and transformant (GvMA#21 and GvMA#28) strains.
![Figure 5. Fermentative intracellular production of prostaglandins F1α, F2α, and F3α in the parental (M. alpina 1S-4) and transformant (GvMA#21 and GvMA#28) strains.](/cms/asset/fa58784b-e9be-47cc-b6ee-071e73bc02c3/tbbb_a_1562880_f0005_b.gif)